Stay tuned for our LIVE OncLive News Network coverage straight from the #ASH18 conference floor! 

Browse by Series:

FDA Approvals in CLL and ALL, NDA Accepted in Melanoma, and More

Gina Columbus
Published: Thursday, Sep 08, 2016



Gina Columbus reports on FDA approvals for blinatumomab in acute lymphoblastic leukemia and ofatumumab in chronic lymphocytic leukemia, encouraging phase III findings with atezolizumab in lung cancer, acceptance of a new drug application for binimetinib in melanoma, and a European approval for crizotinib in lung cancer.
SELECTED
LANGUAGE
Slider Left
Slider Right


Gina Columbus reports on FDA approvals for blinatumomab in acute lymphoblastic leukemia and ofatumumab in chronic lymphocytic leukemia, encouraging phase III findings with atezolizumab in lung cancer, acceptance of a new drug application for binimetinib in melanoma, and a European approval for crizotinib in lung cancer.
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Oncology Best Practice™ Decision Points in Advanced NSCLC: Assessing Treatment Options Beyond Disease ProgressionNov 30, 20181.0
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x